|
|
|
Each of the case studies demonstrates an innovative approach to delivering quality health care at a lower cost. In each case, we find these models of care could be scaled up significantly through provisions already included in the health care bills before Congress. |
| Get Report |
|
|
|
This issue brief examines the many ways our health care system fails small businesses across the country. In addition to drawing on research documenting the scope of these problems, we include testimonials from Michigan small businesses. Their stories illustrate the risk that health care poses for small businesses – and what needs to be done to fix it. |
| Get Report |
|
|
|
A new report identifies policies that could save trillions across the country over the next decade – saving many families, businesses and state economies billions of dollars. It is estimated that implementing the outlined policies would save Michigan $88-109 billion over the next ten years. |
| Get Report |
|
|
|
To more accurately reflect the diversity of views of small businesses on health care, the U.S. Public Interest Research Group has let small business owners speak for themselves. Three hundred and forty-three small business owners and managers across the country made their views heard through a survey which investigated the impact of health care costs on their businesses. |
| Get Report |
|
|
|
As Congressional and public debate over health care reform grows more intense, comparative effectiveness research (CER) has emerged as an unlikely flashpoint of controversy. Opponents’ claims that CER results in the rationing of health care or a government takeover are belied by the true nature of such research: it is simply fundamental scientific research of medical treatments aimed at determining the most effective ways to treat sickness and injury. To improve patient care and reduce the costs of unnecessary and improper treatment, the federal government should expand its funding and support for comparative effectiveness research. |
| Get Report |
|
|
|
Our health care system is in crisis. Without swift action, that crisis could threaten every Michigan family’s health and finances.
|
| Get Report |
|
|
|
Drug companies spend billions annually marketing their latest, most expensive drugs to doctors. These marketing efforts do not rely solely on scientific research and medical benefits, however; they employ a barrage of gifts, expensive meals, and wine-and-dine events to gain access to doctors. |
| Get Report |
|
|
|
Millions of uninsured and underinsured Americans struggle to afford the medicines they need, even forgoing medically necessary drugs when prices are out of reach. When discussing the high cost of prescription drugs, politicians often focus on the financial burden carried by senior citizens. |
| Get Report |
|
|
|
While the pharmaceutical industry is the most profitable industry in the world, millions of uninsured and underinsured Americans struggle to afford the medicines they need, even forgoing medically necessary drugs when prices are out of reach. Meanwhile, the federal government uses its buying power to negotiate fairer prices for the drugs it purchases for its beneficiaries—such as veterans, government employees and retirees. Unfortunately, uninsured individuals have no one doing the same on their behalf. They thus remain at the whim of the pharmaceutical industry, one that has behaved in a manner considered by many to be monopolistic and unethical. |
| Get Report |
